Selenium pretreatment significantly attenuated the experimental colitis.
Selenium pretreatment restored interleukin-10 excretion, as well as reducing the levels of interferon-γ and interleukin-17A.
Selenium corrected DSS-induced imbalance of Th1-Th17/Treg cells.